EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Advances in drug allergy diagnosis and management

Saturday 01 Jun, 13:15 PM - 14:45 PM Valencia, Spain
Granada Oral Abstract Sessions
13:15
Head-to-head comparison between allergist vs. non-allergist in low risk penicillin allergy delabelling: effectiveness, safety and impact on quality of life from a multi-centre, prospective cohort study in Hong Kong (HK-DADI2)
13:27
In-vivo diagnosis in DRESS syndrome: a single center experience
13:39
Assessment of the Impact of Drug Provocation Testing on Anxiety in Patients Experiencing Drug Hypersensitivity Reactions
13:51
Maintaining beta-lactam allergy delabelling in children- a challenge and an opportunity: The CHAD (CHildren Antibiotic Delabeling) follow up study
14:03
Exploration of clinical outcomes for children with and without an antibiotic allergy reviewed by the Children’s Antimicrobial Stewardship Program: A retrospective cohort study
14:15
Retrospective evaluation of the PEN-FAST tool in Patients Undergoing Prolonged Drug Provocation
14:27
The importance of the drug provocation test as a diagnostic tool in immediate hypersensitivity reactions to chemotherapeutics

Speakers